Score Overview
Explore the 2021 public Archive ranking →
Where AngioDynamics Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ANGO
2009: 51.3% · 2021: 71.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 15.54 | — |
1 Year2025-09-26 | $ 10.68 | 45.51% |
5 Years2021-09-28 | $ 23.42 | -33.65% |
10 Years2016-09-28 | $ 17.02 | -8.70% |
20 Years2006-09-28 | $ 20.95 | -25.82% |
All Time2004-05-27 | $ 12.50 | 24.32% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | All Time2004-05-27 |
|---|---|---|---|---|---|---|
| Price | $ 15.54 | $ 10.68 | $ 23.42 | $ 17.02 | $ 20.95 | $ 12.50 |
| Return | — | 45.51% | -33.65% | -8.70% | -25.82% | 24.32% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 313M | -$ 31M | $ 37M |
| 2025 | $ 292M | -$ 33M | $ 55M |
| 2024 | $ 303M | -$ 184M | $ 76M |
| 2023 | $ 338M | -$ 52M | $ 44M |
| 2022 | $ 316M | -$ 26M | $ 28M |
| 2021 | $ 291M | -$ 31M | $ 48M |
| 2020 | $ 264M | -$ 166M | $ 54M |
| 2019 | $ 359M | $ 61M | $ 227M |
| 2018 | $ 344M | $ 16M | $ 75M |
| 2017 | $ 349M | -$ 7M | $ 48M |
| 2016 | $ 353M | -$ 43M | $ 33M |
| 2015 | $ 356M | -$ 3M | $ 20M |
| 2014 | $ 354M | $ 2M | $ 17M |
| 2013 | $ 342M | -$ 1M | $ 23M |
| 2012 | $ 221M | -$ 5M | $ 37M |
| 2011 | $ 215M | $ 8M | $ 131M |
| 2010 | $ 216M | $ 12M | $ 100M |
| 2009 | $ 195M | $ 9M | $ 68M |
| 2008 | $ 166M | $ 10M | $ 78M |
| 2007 | $ 112M | -$ 9M | $ 71M |
| 2006 | $ 78M | $ 6M | $ 89M |
| 2005 | $ 60M | $ 4M | $ 27M |
| IPO2004 | $ 49M | $ 3M | $ 2M |
AngioDynamics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 264M to $ 292M and net income went from -$ 166M to -$ 33M. Revenue increased in 3 of those 5 years; net income in 3.
Across AngioDynamics Inc's full reported history, from 2004 to 2025, revenue grew from $ 49M to $ 292M and net income went from $ 3M to -$ 33M. Revenue increased in 68% of the years measured; net income in 59%.
AngioDynamics Inc currently holds a 20-year HDB Score of 3.3 out of 10. How the HDB Score is calculated.
Membership
Continue ANGO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
